Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Financially Transmitted Diseases

I came up with Financially Transmitted Disease, or FTD TM for short, a couple of years ago. It all happened when I was having dinner with some colleagues discussing quantitative easing (QE) and negative interest rate policy (NIRP). NIRP will have the biggest impact...
Marin Katusa | September 13, 2019 |

Buzz on the Bullboards: New Year, New Stocks?

The beginning of a new year always sparks hope and signals new possibilities — and that same logic can be applied to the stock market. 2021 certainly had its plethora of ups and downs, but the Canadian market finished off the year strong and the sentiment remains bul...
Stockhouse Editorial | January 5, 2022 |

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

ProMIS' preclinical treatment could possibly outshine Biogen's candidate. Finding an effective treatment for Alzheimer's disease has been elusive as many seemingly promising avenues of research did not prove out in clinical trials. Biogen Inc. (BIIB:NASDAQ) appeared...
Streetwise Reports | November 7, 2019 |

East-West Trade War: Never Take a Knife to a Gunfight

It's a funny thing that happens when the stress of financial insolvency bubbles up to the surface. Decisions once considered "routine" (like brushing one's teeth or walking one's dog) suddenly have life-or-death outcomes, complete with cold sweats, sleepless nights and ...
Streetwise Reports | October 11, 2019 |

Smart Irrigation Solutions – Vital Technology Helping with the Global Water Crisis

Water Ways Technology is a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers. With 138 projects complete, their mission is to make agricultural technology accessible across the globe. Recently, The ...
Daniella Atkinson | November 24, 2022 |

Gapping Rotation in SPY and News Based Rallies Are A Warning

As holiday trading sets up in the global markets, the SPY is starting to show signs of volatility and warning of a potential top by gapping as price attempts to trade sideways. This type of top formation, along with the fact that the overnight REPO facility continues to roil t...
Chris Vermeulen | December 13, 2019 |

Mar 27th 2020, Silver Chartbook – Brace yourself

Brace yourself Right now you might find yourself in this first moment of catching a breath. You might have started getting used to a work from home. In addition, you might be feeling more prepared having stacked up on essentials. Maybe you even got used to this new wo...
Korbinian Koller | March 27, 2020 |

Buzz on the Bullboards: A diagnosis on the health of the economy

It has been a bit of a stalemate for North American markets this week as indices nudged one way or another. Earnings report have been rolling in, with some major U.S. banks reporting a slowdown in profits, others saw better-than-expected earnings. Traders are tracking an ...
Jonathon Brown | April 20, 2023 |

Can Amazon stock retain its Magnificent Seven position?

Amazon.com Inc. (NDAQ:AMZN) is one of the S&P 500’s Magnificent Seven Amazon shares were up more than 85 per cent the past year and have doubled over the past five years Amazon’s target price is around US$200, implying an...
Coreena Robertson | April 17, 2024 |

A Groundswell of Investor Support is a Signal That NZP is on The Right Track

Chatham Rock Phosphate Limited (TSXV: “ NZP ” and NZX: “CRP”) provides shareholders and stakeholders with another of our regular updates. The last few months have been very good for CRP and its shareholders. A combination o...
Featured Submission | February 23, 2021 |
1 2 3 4